This healthcare stock which is a leading manufacturer and exporter of medical devices, specializing in products for oncology, infusion therapy, cardiology, and various other healthcare applications, skyrocketed 11.66 percent it reported its quarterly result and announced revenue guidance of more than 20 percent revenue growth over the next 2 to 3 years. Stock Price Movement … Continue reading Stock jumps 12% after reporting 31% YoY net profit growth; Announces 20% revenue guidance